FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WU, Z. L.
Right arrow Articles by ROSENBERG, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WU, Z. L.
Right arrow Articles by ROSENBERG, R. D.
(The FASEB Journal. 2002;16:539-545.)
© 2002 FASEB

A new strategy for defining critical functional groups on heparan sulfate

ZHENGLIANG L. WU, LIJUAN ZHANG, DAVID L. BEELER, B. KUBERAN and ROBERT D. ROSENBERG1

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

1Correspondence: Massachusetts Institute of Technology, Bldg. 68–480, 77 Massachusetts Ave., Cambridge, MA 02139, USA. E-mail: rdrrosen{at}mit.edu

Heparan sulfate (HS) is a sulfated polysaccharide present on cell surfaces and in the extracellular matrix. Accumulating evidence shows that HS plays key roles in many biological systems by interacting with various proteins in a structural-specific manner. Due to technical difficulties, however, the understanding of critical functional groups on HS for protein interaction is vague. We report a rapid, convenient, sensitive, and inexpensive strategy using in vitro modification with pure enzymes and gel mobility shift assay to study the subject. We demonstrated the requirements of 3-O, 6-O sulfates and the minimal length of oligosaccharide for antithrombin III (AT-III) binding. We regenerated the binding sites for AT-III on completely desulfated N-resulfated heparin and revealed the critical modification enzymes. This new strategy could be used to identify critical functional groups on HS and to generate HS library and biologically active HS, providing information applicable to the design of HS drugs, such as anticoagulant reagents and viral infection blockers. The binding assay with fibroblast growth factors and receptors confirmed the general usefulness of this approach.—Wu, Z. L., Zhang, L., Beeler, D. L., Kuberan, B., Rosenberg, R. D. A new strategy for defining critical functional groups on heparan sulfate.


Key Words: heparin • gel mobility shift assay • in vitro modification • antithrombin III • sulfotransferase




This article has been cited by other articles:


Home page
GlycobiologyHome page
N. T. Seyfried, C. D. Blundell, A. J. Day, and A. Almond
Preparation and application of biologically active fluorescent hyaluronan oligosaccharides
Glycobiology, March 1, 2005; 15(3): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
C. Pisano, C. Aulicino, L. Vesci, B. Casu, A. Naggi, G. Torri, D. Ribatti, M. Belleri, M. Rusnati, and M. Presta
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist
Glycobiology, February 1, 2005; 15(2): 1C - 6C.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Pankonin, J. T. Gallagher, and J. A. Loeb
Specific Structural Features of Heparan Sulfate Proteoglycans Potentiate Neuregulin-1 Signaling
J. Biol. Chem., January 7, 2005; 280(1): 383 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lyon, J. A. Deakin, D. Lietha, E. Gherardi, and J. T. Gallagher
The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay: ELUCIDATION OF THE MINIMAL SIZE OF BINDING AND ACTIVATORY OLIGOSACCHARIDES
J. Biol. Chem., October 15, 2004; 279(42): 43560 - 43567.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. K. Powell, E. A. Yates, D. G. Fernig, and J. E. Turnbull
Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and experimental approaches
Glycobiology, April 1, 2004; 14(4): 17R - 30R.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. L. Wu, M. Lech, D. L. Beeler, and R. D. Rosenberg
Determining Heparan Sulfate Structure in the Vicinity of Specific Sulfotransferase Recognition Sites by Mass Spectrometry
J. Biol. Chem., January 16, 2004; 279(3): 1861 - 1866.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Kuberan, D. L. Beeler, M. Lech, Z. L. Wu, and R. D. Rosenberg
Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides
J. Biol. Chem., December 26, 2003; 278(52): 52613 - 52621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. L. Wu, L. Zhang, T. Yabe, B. Kuberan, D. L. Beeler, A. Love, and R. D. Rosenberg
The Involvement of Heparan Sulfate (HS) in FGF1/HS/FGFR1 Signaling Complex
J. Biol. Chem., May 2, 2003; 278(19): 17121 - 17129.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
F. M. El-Fasakhany, K. Ichihara-Tanaka, K. Uchimura, and T. Muramatsu
N-Acetylglucosamine-6-O-Sulfotransferase-1: Production in the Baculovirus System and Its Applications to the Synthesis of a Sulfated Oligosaccharide and to the Modification of Oligosaccharides in Fibrinogen
J. Biochem., March 1, 2003; 133(3): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jemth, J. Kreuger, M. Kusche-Gullberg, L. Sturiale, G. Gimenez-Gallego, and U. Lindahl
Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs. EXPLORING THE STRUCTURAL DIVERSITY BY SCREENING FOR FIBROBLAST GROWTH FACTOR (FGF) 1 AND FGF2 BINDING
J. Biol. Chem., August 16, 2002; 277(34): 30567 - 30573.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The Federation of American Societies for Experimental Biology.